Physician profile
Gregory Bonner
NPI 1932211224
$4,036.50
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,217 · 2020: $996 · 2021: $1,343 · 2022: $481.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,571.20 | 2019-2022 | |
| Braintree Laboratories, INC. | $493.49 | 2019-2022 | |
| Janssen Biotech, INC. | $431.40 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $368.64 | 2019-2021 | |
| Gilead Sciences, INC. | $324.92 | 2019-2022 | |
| Pfizer INC. | $152.38 | 2019-2022 | |
| Celgene Corporation | $95.68 | 2021-2022 | |
| Redhill Biopharma INC. | $84.33 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $77.19 | 2020-2021 | |
| Ironwood Pharmaceuticals, INC | $68.78 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $67.46 | 2019-2022 | |
| Organon LLC | $64.45 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $45.08 | 2020-2021 | |
| Ucb, INC. | $36.48 | 2019-2020 | |
| Allergan, INC. | $33.03 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $32.98 | 2019-2021 | |
| Micro-Tech Endoscopy USA, INC. | $21.69 | 2022 | |
| Merck Sharp & Dohme LLC | $19.10 | 2019 | |
| Vivus LLC | $19.10 | 2021 | |
| Alfasigma USA, INC. | $17.30 | 2021 | |
| Intercept Pharmaceuticals, INC. | $11.82 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Bonner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.